A review of current therapeutics targeting the mitochondrial protease ClpP in diffuse midline glioma, H3 K27-altered
2023 · Neuro-Oncology · 29 citations
https://doi.org/10.1093/neuonc/noad144
E
Evangeline R. Jackson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
64
Papers
454
Citations
10
h-index
10
i10-index
Evangeline R. Jackson is an academic researcher from Hunter Medical Research Institute. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Neuroblastoma Research and Treatments & ATP Synthase and ATPases Research. The author has an h-index of 10, co-authored 55 publications.
ORCID: 0000-0002-2245-9213Papers by this author
worksBlockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies
2023 · Science Signaling · 22 citations
https://doi.org/10.1126/scisignal.abp9586
Current status and advances to improving drug delivery in diffuse intrinsic pontine glioma
2024 · Journal of Controlled Release · 18 citations
https://doi.org/10.1016/j.jconrel.2024.05.018
Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma
2023 · Neoplasia · 14 citations
https://doi.org/10.1016/j.neo.2023.100921
Additional file 2 of Correction to: Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.22619141
Additional file 2 of Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.22607053
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat